Jean Francois Formela, Director at Intellia Therapeutics, Inc. (NTLA), sold 80,000 shares at $16.07 ($1.3M) on 2017-07-11, disclosed to the SEC on 2017-07-11.
Open-market sale of $1.3M NTLA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KRRO | SELL | 2026-08-21 | $399K | — | Filing → |
| KRRO | SELL | 2026-08-13 | $30K | — | Filing → |
| KRRO | SELL | 2026-07-07 | $1.5M | — | Filing → |